Human Circulating MicroRNA-1 and MicroRNA-126 as Potential Novel Indicators for Acute Myocardial Infarction

Circulating miRNAs have been shown as promising biomarkers for various pathologic conditions. The aim of this study was to clarify that circulating miR-1 and miR-126 in human plasma might be useful as biomarkers in acute myocardial infarction (AMI). In our study, after pre-test, two candidate miRNAs were detected by using real-time RT-PCR. Cardiac troponin I (cTnI) concentrations were measured by ELISA assay in plasma from patients with AMI (n=17) and healthy subjects (n=25), simultaneously. Increased miR-1 and decreased miR-126 in plasma from patients with AMI after the onset of symptoms compared with healthy subjects were found. A remarkable finding in this study is that miR-1, miR-126 and cTnI expression levels exhibited the same trend. Our results suggest that the plasma concentrations of miR-1 and miR-126 may be useful indicators for AMI.

[1]  M. Rossbach.  Small non-coding RNAs as novel therapeutics. , 2010, Current molecular medicine.

[2]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[3]  J. Bauersachs.  Regulation of Myocardial Fibrosis by MicroRNAs , 2010, Journal of cardiovascular pharmacology.

[4]  Fred S Apple,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Circulation.

[5]  H. Jäck,et al.  Serum microRNAs as powerful cancer biomarkers. , 2010, Biochimica et biophysica acta.

[6]  N. Iwai,et al.  The Monocyte Chemotactic Protein-1 Gene May Contribute to Hypertension in Dahl Salt-Sensitive Rats , 2007, Hypertension Research.

[7]  D. Glavač,et al.  MicroRNA Microarray Expression Profiling in Human Myocardial Infarction , 2010, Disease markers.

[8]  P. Qi,et al.  Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection , 2011, PloS one.

[9]  K. Fogarty,et al.  MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis , 2010, Nature.

[10]  Robert H Christenson,et al.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. , 2007, Clinical chemistry.

[11]  Dmitry Terentyev,et al.  MicroRNA-1 and -133 Increase Arrhythmogenesis in Heart Failure by Dissociating Phosphatase Activity from RyR2 Complex , 2011, PloS one.

[12]  E. van Rooij,et al.  Therapeutic Advances in MicroRNA Targeting , 2011, Journal of cardiovascular pharmacology.

[13]  Federica Limana,et al.  Circulating microRNAs are new and sensitive biomarkers of myocardial infarction , 2010, European heart journal.

[14]  Ning Wang,et al.  MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation , 2010, Circulation.

[15]  Offer Amir,et al.  Serum levels of microRNAs in patients with heart failure , 2012, European journal of heart failure.

[16]  D. Glavač,et al.  MicroRNAs miR-1, miR-133a, miR-133b and miR-208 Are Dysregulated in Human Myocardial Infarction , 2009, Cardiology.

[17]  Decheng Yang,et al.  MicroRNA: an Emerging Therapeutic Target and Intervention Tool , 2008, International journal of molecular sciences.

[18]  M. Ivan,et al.  microRNA: emerging therapeutic targets in acute ischemic diseases. , 2010, Pharmacology & therapeutics.

[19]  Wei Gao,et al.  Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction , 2010, BMC cardiovascular disorders.

[20]  Chaoqian Xu,et al.  Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA‐1 , 2009, British journal of pharmacology.

[21]  Yanjie Lu,et al.  MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases , 2010, Acta Pharmacologica Sinica.

[22]  Q. Cui,et al.  An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.

[23]  I. Rigoutsos,et al.  Gene-expression forum: Decoy for microRNAs , 2010, Nature.

[24]  Chaoqian Xu,et al.  MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. , 2009, Cardiovascular research.

[25]  Jayaram Radhakrishnan,et al.  LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors , 2007, Science.

[26]  D. Moazed.  Small RNAs in transcriptional gene silencing and genome defence , 2009, Nature.

[27]  M. Abdellatif.  MicroRNA: redefining mechanisms in cardiovascular diseases. , 2010, Journal of cardiovascular pharmacology.

[28]  E. Olson,et al.  MicroRNA-218 Regulates Vascular Patterning by Modulation of Slit-Robo Signaling , 2010, Circulation research.

[29]  M. Medvedovic,et al.  MicroRNA-494 Targeting Both Proapoptotic and Antiapoptotic Proteins Protects Against Ischemia/Reperfusion-Induced Cardiac Injury , 2010, Circulation.

[30]  Xuemei Chen,et al.  Degradation of microRNAs by a Family of Exoribonucleases in Arabidopsis , 2008, Science.

[31]  Volker Adams,et al.  Cardiovascular Effects of Exercise Training: Molecular Mechanisms , 2010, Circulation.

[32]  G. Hirokawa,et al.  Plasma miR-208 as a biomarker of myocardial injury. , 2009, Clinical chemistry.

[33]  W. Rottbauer,et al.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.

[34]  Wei Wu.  MicroRNA: Potential Targets for the Development of Novel Drugs? , 2010, Drugs in R&D.

[35]  Chaoqian Xu,et al.  The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2 , 2011, Nature Medicine.

[36]  Hui Zhou,et al.  Insulin-Like Growth Factor-1 Receptor Is Regulated by microRNA-133 during Skeletal Myogenesis , 2011, PloS one.

[37]  Anthony Boureux,et al.  Maternal mRNA deadenylation and decay by the piRNA pathway in the early Drosophila embryo , 2010, Nature.

[38]  M. Latronico,et al.  Emerging role of microRNAs in cardiovascular biology. , 2007, Circulation research.

[39]  I. Wistuba,et al.  TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs , 2010, Nature.

[40]  Stefanie Dimmeler,et al.  Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[41]  W. Yue,et al.  MicroRNA-21 Overexpression Contributes to Vestibular Schwannoma Cell Proliferation and Survival , 2010, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[42]  Kang Li,et al.  Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. , 2010, Biochemical and biophysical research communications.